Key result
A 22-year-old man with type 1 myotonic dystrophy and Brugada syndrome received an ICD and experienced an appropriate shock for rapid polymorphic ventricular tachycardia 8 months post-implantation.
Why the study?
Cardiac electrical disturbances are common in myotonic dystrophy Type 1, but data suggesting an increased prevalence of Brugada syndrome in this population are limited.
Does ICD implantation prevent sudden cardiac death in a young patient with type 1 myotonic dystrophy and Brugada syndrome?
Case Report (n=1)
Does ICD implantation prevent sudden cardiac death in a young patient with type 1 myotonic dystrophy and Brugada syndrome?
ICD implantation can be life-saving in patients with myotonic dystrophy type 1 and concomitant Brugada syndrome who are at risk for sudden cardiac death.
Answers are grounded in this paper and cite their sources.
May warrant ECG vigilance in MD1 families; leaves open whether Brugada screening alters outcomes.
BACKGROUND: Cardiac electrical disturbances represent the most frequent cardiac manifestations of myotonic dystrophy Type 1 (MD1). Limited data suggest that the prevalence of Brugada syndrome in MD1 may be increased compared to the general population. CASE SUMMARY: We report a case of a 22-year-old asymptomatic man with repolarization abnormalities in leads V1-V3 suggestive of Type III Brugada pattern. The patient had a family history of MD and incidents of sudden death in relatives. Drug-induced Brugada Type 1 syndrome was revealed after procainamide challenge. A ventricular stimulation study was positive since a polymorphic ventricular tachycardia was induced after two extrastimuli. The patient underwent implantation of a single chamber cardiac defibrillator (ICD). Eight months after the procedure he suffered an appropriate ICD shock due to rapid polymorphic ventricular tachycardia. DISCUSSION: Brugada syndrome is linked with MD1. Potential life-threatening arrhythmias may develop in the adult life of MD1 patients. Electrocardiographic surveillance and tailored invasive treatment with ICDs can prevent sudden cardiac death in this setting.
No takes yet. Share an insight, caveat, or question.
Korantzopoulos et al. (2019) conducted a case report in Brugada syndrome and type 1 myotonic dystrophy (n=1). Implantable cardioverter defibrillator (ICD) was evaluated on Appropriate ICD shock due to rapid polymorphic ventricular tachycardia. A 22-year-old man with type 1 myotonic dystrophy and Brugada syndrome received an ICD and experienced an appropriate shock for rapid polymorphic ventricular tachycardia 8 months post-implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: